glp 1 pharma companies 3 at the Forefront of the GLP-1 Pill Wars GLP-1 Drugs and The Pharma

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

with personalized nutrition coaching

Weight loss medications like Ozempic and Wegovy can help people drop pounds quickly, but they can also cause a rapid loss of muscle mass and bone density unless lifestyle changes are made.

Millions of patients now use these medicines for blood sugar control, weight reduction, and cardiovascular risk improvement

Grateful if you can share this

With the growth of the GLP-1 user base, the impact of the medications on the market is equally expanding